US Stock MarketDetailed Quotes

BLUE bluebird bio

Watchlist
  • 0.350
  • +0.052+17.52%
Close Nov 22 16:00 ET
  • 0.349
  • -0.001-0.31%
Post 19:57 ET
68.07MMarket Cap-194P/E (TTM)

bluebird bio Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-37.72%-68.93M
-11.35%-66.25M
-4.65%-74.68M
25.67%-235.05M
-177.07%-54.14M
35.02%-50.05M
36.94%-59.5M
43.05%-71.36M
50.25%-316.22M
86.02%-19.54M
Net income from continuing operations
30.29%-60.81M
-29.63%-81.39M
-468.75%-69.8M
8.00%-211.91M
-218.04%-80.82M
-14.00%-87.23M
37.30%-62.79M
115.50%18.93M
71.89%-230.34M
144.16%68.47M
Operating gains losses
163.38%495K
213.29%196K
-619.44%-777K
109.27%167K
124.90%1.23M
---781K
-127.59%-173K
-104.31%-108K
---1.8M
---4.94M
Depreciation and amortization
107.07%15.34M
171.90%16.53M
150.63%15.47M
241.86%28.53M
92.76%8.87M
434.25%7.41M
352.23%6.08M
508.68%6.17M
-57.53%8.34M
98.75%4.6M
Other non cash items
-77.00%7.03M
3.00%6.84M
107.22%6.05M
41.55%-36.9M
114.76%9.75M
1,270.35%30.55M
1,307.20%6.64M
-44,453.97%-83.83M
-458.19%-63.12M
-1,837.11%-66.01M
Change In working capital
-2,077.56%-28.02M
8.04%-17.2M
-43.76%-29.47M
33.74%-49.72M
59.38%-11.93M
110.63%1.42M
-235.81%-18.71M
23.42%-20.5M
-517.26%-75.04M
-78.10%-29.38M
-Change in inventory
-159.47%-22.31M
30.36%-8.54M
-34.78%-7.19M
-405.88%-36.56M
-43.39%-10.36M
---8.6M
-240.11%-12.27M
39.12%-5.33M
60.82%-7.23M
---7.23M
-Change in prepaid assets
-238.96%-11.89M
-685.28%-21.6M
-266.71%-13.53M
19.21%-3.89M
-536.53%-6.01M
149.33%8.56M
48.35%-2.75M
14.27%-3.69M
8.87%-4.82M
-86.80%1.38M
-Change in payables and accrued expense
-58.28%5.16M
461.21%18.4M
-17.45%-5.91M
140.10%19.62M
486.59%9M
173.41%12.38M
120.96%3.28M
64.30%-5.03M
-199.22%-48.93M
68.84%-2.33M
-Change in other current liabilities
-29.76%-7.02M
21.06%-5.46M
55.29%-2.84M
-105.28%-28.89M
-220.71%-10.2M
54.62%-5.41M
-54.56%-6.92M
-3.80%-6.36M
56.22%-14.07M
210.57%8.45M
-Change in other working capital
----
----
----
----
----
--9.09M
---53K
---85K
----
----
Cash from discontinued investing activities
Operating cash flow
-37.72%-68.93M
-11.35%-66.25M
-4.65%-74.68M
25.67%-235.05M
-177.07%-54.14M
35.02%-50.05M
36.94%-59.5M
43.05%-71.36M
50.25%-316.22M
86.02%-19.54M
Investing cash flow
Cash flow from continuing investing activities
-99.25%466K
-76.66%1.62M
-100.80%-655K
-38.13%154.95M
-96.33%3.79M
297.74%62.08M
-88.74%6.95M
17.46%82.14M
-55.48%250.45M
69.44%103.24M
Net PPE purchase and sale
86.26%-280K
91.63%-59K
-665.09%-1.78M
48.96%-4.19M
-1,024.07%-1.21M
-61.23%-2.04M
88.21%-705K
72.93%-232K
-108.57%-8.21M
93.07%-108K
Net intangibles purchase and sale
--0
--0
--0
2.64%-4.87M
20.00%-4M
--0
--0
---868K
41.18%-5M
-900.00%-5M
Net investment purchase and sale
--0
--0
--0
-56.03%71.08M
41.73%9M
280.02%64.12M
-88.63%7.69M
-113.75%-9.74M
-65.98%161.66M
-89.92%6.35M
Net other investing changes
--746K
4,100.00%1.68M
-98.80%1.12M
-8.89%92.93M
--0
--0
---42K
--92.97M
--102M
----
Cash from discontinued investing activities
Investing cash flow
-99.25%466K
-76.66%1.62M
-100.80%-655K
-38.13%154.95M
-96.33%3.79M
297.74%62.08M
-88.74%6.95M
17.46%82.14M
-55.48%250.45M
69.44%103.24M
Financing cash flow
Cash flow from continuing financing activities
48.42%-6.11M
55.66%-6.06M
-43.87%64.65M
1,020.20%196.25M
389.23%106.58M
-125.55%-11.84M
-270.14%-13.67M
1,279,633.33%115.18M
118.65%17.52M
78.82%-36.85M
Net issuance payments of debt
-77.46%-20.93M
-99.90%-26.44M
421.37%49.11M
-48.00%-54.37M
---14.07M
---11.8M
---13.22M
---15.28M
---36.73M
----
Net common stock issuance
--0
--0
--0
357.62%248.2M
92,385.94%118.13M
-100.11%-50K
-106.50%-523K
--130.65M
-27.66%54.24M
-1,728.57%-128K
Proceeds from stock option exercised by employees
33,262.50%2.67M
-3,521.79%-2.67M
1,512.17%2.67M
----
----
166.67%8K
966.67%78K
-2,200.00%-189K
----
----
Net other financing activities
--12.16M
--23.04M
--12.87M
15,006.25%2.42M
----
----
----
----
100.01%16K
----
Cash from discontinued financing activities
Financing cash flow
48.42%-6.11M
55.66%-6.06M
-43.87%64.65M
1,020.20%196.25M
389.23%106.58M
-125.55%-11.84M
-270.14%-13.67M
1,279,633.33%115.18M
118.65%17.52M
78.82%-36.85M
Net cash flow
Beginning cash position
-11.44%193.22M
-7.20%263.91M
73.31%274.6M
-23.34%158.45M
95.69%218.37M
72.22%218.17M
87.93%284.4M
-23.34%158.45M
-44.69%206.69M
-75.71%111.59M
Current changes in cash
-38,339.49%-74.57M
-6.75%-70.69M
-108.48%-10.69M
340.74%116.15M
20.01%56.23M
101.29%195K
-168.68%-66.23M
327.51%125.95M
71.12%-48.25M
118.53%46.85M
End cash Position
-45.66%118.65M
-11.44%193.22M
-7.20%263.91M
73.31%274.6M
73.31%274.6M
95.69%218.37M
72.22%218.17M
87.93%284.4M
-23.34%158.45M
-23.34%158.45M
Free cash flow
-32.86%-69.21M
-10.14%-66.31M
-5.51%-76.45M
25.90%-244.1M
-140.80%-59.35M
33.47%-52.09M
40.00%-60.21M
42.56%-72.46M
49.98%-329.43M
82.62%-24.65M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -37.72%-68.93M-11.35%-66.25M-4.65%-74.68M25.67%-235.05M-177.07%-54.14M35.02%-50.05M36.94%-59.5M43.05%-71.36M50.25%-316.22M86.02%-19.54M
Net income from continuing operations 30.29%-60.81M-29.63%-81.39M-468.75%-69.8M8.00%-211.91M-218.04%-80.82M-14.00%-87.23M37.30%-62.79M115.50%18.93M71.89%-230.34M144.16%68.47M
Operating gains losses 163.38%495K213.29%196K-619.44%-777K109.27%167K124.90%1.23M---781K-127.59%-173K-104.31%-108K---1.8M---4.94M
Depreciation and amortization 107.07%15.34M171.90%16.53M150.63%15.47M241.86%28.53M92.76%8.87M434.25%7.41M352.23%6.08M508.68%6.17M-57.53%8.34M98.75%4.6M
Other non cash items -77.00%7.03M3.00%6.84M107.22%6.05M41.55%-36.9M114.76%9.75M1,270.35%30.55M1,307.20%6.64M-44,453.97%-83.83M-458.19%-63.12M-1,837.11%-66.01M
Change In working capital -2,077.56%-28.02M8.04%-17.2M-43.76%-29.47M33.74%-49.72M59.38%-11.93M110.63%1.42M-235.81%-18.71M23.42%-20.5M-517.26%-75.04M-78.10%-29.38M
-Change in inventory -159.47%-22.31M30.36%-8.54M-34.78%-7.19M-405.88%-36.56M-43.39%-10.36M---8.6M-240.11%-12.27M39.12%-5.33M60.82%-7.23M---7.23M
-Change in prepaid assets -238.96%-11.89M-685.28%-21.6M-266.71%-13.53M19.21%-3.89M-536.53%-6.01M149.33%8.56M48.35%-2.75M14.27%-3.69M8.87%-4.82M-86.80%1.38M
-Change in payables and accrued expense -58.28%5.16M461.21%18.4M-17.45%-5.91M140.10%19.62M486.59%9M173.41%12.38M120.96%3.28M64.30%-5.03M-199.22%-48.93M68.84%-2.33M
-Change in other current liabilities -29.76%-7.02M21.06%-5.46M55.29%-2.84M-105.28%-28.89M-220.71%-10.2M54.62%-5.41M-54.56%-6.92M-3.80%-6.36M56.22%-14.07M210.57%8.45M
-Change in other working capital ----------------------9.09M---53K---85K--------
Cash from discontinued investing activities
Operating cash flow -37.72%-68.93M-11.35%-66.25M-4.65%-74.68M25.67%-235.05M-177.07%-54.14M35.02%-50.05M36.94%-59.5M43.05%-71.36M50.25%-316.22M86.02%-19.54M
Investing cash flow
Cash flow from continuing investing activities -99.25%466K-76.66%1.62M-100.80%-655K-38.13%154.95M-96.33%3.79M297.74%62.08M-88.74%6.95M17.46%82.14M-55.48%250.45M69.44%103.24M
Net PPE purchase and sale 86.26%-280K91.63%-59K-665.09%-1.78M48.96%-4.19M-1,024.07%-1.21M-61.23%-2.04M88.21%-705K72.93%-232K-108.57%-8.21M93.07%-108K
Net intangibles purchase and sale --0--0--02.64%-4.87M20.00%-4M--0--0---868K41.18%-5M-900.00%-5M
Net investment purchase and sale --0--0--0-56.03%71.08M41.73%9M280.02%64.12M-88.63%7.69M-113.75%-9.74M-65.98%161.66M-89.92%6.35M
Net other investing changes --746K4,100.00%1.68M-98.80%1.12M-8.89%92.93M--0--0---42K--92.97M--102M----
Cash from discontinued investing activities
Investing cash flow -99.25%466K-76.66%1.62M-100.80%-655K-38.13%154.95M-96.33%3.79M297.74%62.08M-88.74%6.95M17.46%82.14M-55.48%250.45M69.44%103.24M
Financing cash flow
Cash flow from continuing financing activities 48.42%-6.11M55.66%-6.06M-43.87%64.65M1,020.20%196.25M389.23%106.58M-125.55%-11.84M-270.14%-13.67M1,279,633.33%115.18M118.65%17.52M78.82%-36.85M
Net issuance payments of debt -77.46%-20.93M-99.90%-26.44M421.37%49.11M-48.00%-54.37M---14.07M---11.8M---13.22M---15.28M---36.73M----
Net common stock issuance --0--0--0357.62%248.2M92,385.94%118.13M-100.11%-50K-106.50%-523K--130.65M-27.66%54.24M-1,728.57%-128K
Proceeds from stock option exercised by employees 33,262.50%2.67M-3,521.79%-2.67M1,512.17%2.67M--------166.67%8K966.67%78K-2,200.00%-189K--------
Net other financing activities --12.16M--23.04M--12.87M15,006.25%2.42M----------------100.01%16K----
Cash from discontinued financing activities
Financing cash flow 48.42%-6.11M55.66%-6.06M-43.87%64.65M1,020.20%196.25M389.23%106.58M-125.55%-11.84M-270.14%-13.67M1,279,633.33%115.18M118.65%17.52M78.82%-36.85M
Net cash flow
Beginning cash position -11.44%193.22M-7.20%263.91M73.31%274.6M-23.34%158.45M95.69%218.37M72.22%218.17M87.93%284.4M-23.34%158.45M-44.69%206.69M-75.71%111.59M
Current changes in cash -38,339.49%-74.57M-6.75%-70.69M-108.48%-10.69M340.74%116.15M20.01%56.23M101.29%195K-168.68%-66.23M327.51%125.95M71.12%-48.25M118.53%46.85M
End cash Position -45.66%118.65M-11.44%193.22M-7.20%263.91M73.31%274.6M73.31%274.6M95.69%218.37M72.22%218.17M87.93%284.4M-23.34%158.45M-23.34%158.45M
Free cash flow -32.86%-69.21M-10.14%-66.31M-5.51%-76.45M25.90%-244.1M-140.80%-59.35M33.47%-52.09M40.00%-60.21M42.56%-72.46M49.98%-329.43M82.62%-24.65M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Investment Theme Gene Editing
Gene Editing
Intraday+0.82%
CAR-T Therapy
CAR-T Therapy
Intraday+0.65%
Top Gainers Yesterday
Top Gainers Yesterday
Intraday-0.25%